Fundz
Real-time · AI · Cross-signal

Discover the power of real-time signals plus AI

Every contract, funding round, exec hire, and M&A move on Illumina Hong Kong LIMITED (Illumina) and PHASE Scientific International Limited (PHASE) — with verified, ICP-scored contact reveals (email + mobile) on demand.

Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.

See plansBook a 15-min walkthrough
▶
Watch the 2-minute tour · with sound

Illumina and PHASE Partner to Advance Oncology Testing in the Greater Bay Area

Nov 08, 2024•over 1 year ago

Contract Type

partnership

ChinaBiotechnology

Description

Illumina and PHASE have signed a three-year Memorandum of Understanding (MoU) to engage in deep collaboration in the Greater Bay Area (GBA) to jointly shape Comprehensive Genomic Profiling (CGP) consensus policy and enhance awareness and endorsement of Illumina’s oncology testing products.

Company Information

Company

Illumina Hong Kong LIMITED (Illumina) and PHASE Scientific International Limited (PHASE)

Location

China

About

Illumina Hong Kong LIMITED is a global leader in DNA sequencing and array-based technologies. PHASE Scientific International Limited is a Hong Kong-based biotech company with operations in the U.S. and the Greater Bay Area (GBA).

Predictive Intelligence
Strategic

ML-powered predictions for Illumina Hong Kong LIMITED (Illumina) and PHASE Scientific International Limited (PHASE)'s next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months